Lisata Therapeutics (LSTA) Short Interest Ratio & Short Volume

Short interest is the volume of Lisata Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 20,600 shares of LSTA short. 0.31% of Lisata Therapeutics' shares are currently sold short. Learn More on Lisata Therapeutics' current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Lisata Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.31% of Lisata Therapeutics' floating shares are currently sold short.

Lisata Therapeutics saw a drop in short interest during the month of January. As of January 31st, there was short interest totaling 20,600 shares, a drop of 16.9% from the previous total of 24,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Lisata Therapeutics currently has issued a total of 8,395,000 shares. Some of Lisata Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lisata Therapeutics currently has a public float of 6,560,000 shares.

0.31% of Lisata Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lisata Therapeutics: Oramed Pharmaceuticals Inc. (0.57%), Protara Therapeutics, Inc. (20.36%), X4 Pharmaceuticals, Inc. (9.74%), Immunic, Inc. (4.16%), Mersana Therapeutics, Inc. (7.67%), DBV Technologies S.A. (1.75%), Cellectis S.A. (0.40%), Scilex Holding (2.42%), Cue Biopharma, Inc. (1.74%), Acumen Pharmaceuticals, Inc. (4.19%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

Short selling LSTA is an investing strategy that aims to generate trading profit from Lisata Therapeutics as its price is falling. LSTA shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Lisata Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LSTA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LSTA, twice per month. The most recent reporting period available is January, 31 2025.